Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
11.27
-0.04 (-0.35%)
Nov 21, 2024, 4:00 PM EST - Market closed
Stoke Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 597 | 235 | 364 | 883 | 2,244 | 927 | |
| Market Cap Growth | 270.77% | -35.46% | -58.77% | -60.67% | 142.11% | - | |
| Enterprise Value | 333 | 23 | 118 | 652 | 2,054 | 694 | |
| Last Close Price | 11.27 | 5.26 | 9.23 | 23.99 | 61.93 | 28.32 | |
| PS Ratio | 34.32 | 26.75 | 29.34 | - | - | - | |
| PB Ratio | 2.57 | 1.47 | 1.97 | 4.05 | 7.84 | 4.13 | |
| P/TBV Ratio | 2.79 | 1.47 | 1.97 | 4.05 | 7.84 | 4.13 | |
| EV/Sales Ratio | 19.89 | 2.67 | 9.51 | - | - | - | |
| Debt / Equity Ratio | 0.02 | 0.04 | 0.03 | 0.02 | 0.00 | - | |
| Asset Turnover | 0.06 | 0.04 | 0.05 | - | - | - | |
| Quick Ratio | 4.81 | 6.54 | 7.33 | 12.83 | 25.15 | 54.32 | |
| Current Ratio | 5.09 | 6.99 | 7.77 | 13.37 | 25.73 | 55.12 | |
| Return on Equity (ROE) | -52.06% | -60.80% | -50.20% | -34.06% | -20.47% | -19.62% | |
| Return on Assets (ROA) | -27.50% | -29.62% | -26.36% | -20.04% | -12.59% | -13.26% | |
| Return on Capital (ROIC) | -35.44% | -40.26% | -31.60% | -21.09% | -12.96% | -13.54% | |
| Earnings Yield | -17.67% | -44.58% | -27.77% | -9.72% | -2.33% | -3.49% | |
| FCF Yield | -14.19% | -35.20% | -9.84% | -7.72% | -1.93% | -3.53% | |
| Buyback Yield / Dilution | -19.65% | -13.10% | -5.87% | -9.71% | -86.34% | -2433.56% | |
| Total Shareholder Return | -19.65% | -13.10% | -5.87% | -9.71% | -86.34% | -2433.56% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.